Evidence map›Paper›PMID 35172901›Full record

ArticleArthritis research & therapy2022

A comprehensive profile of chemokines in the peripheral blood and vascular tissue of patients with Takayasu arteritis.

Xiufang Kong, Sifan Wu, Xiaojuan Dai, Wensu Yu, Jinghua Wang, Ying Sun, Zongfei Ji, Lingying Ma, Xiaomin Dai, Huiyong Chen and 2 more

Open access · goldAbstract read
In one paragraph

Article in Arthritis research & therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Xiufang KongDepartment of Rheumatology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Sifan WuDepartment of Rheumatology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Xiaojuan DaiDepartment of Rheumatology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Wensu YuDepartment of Rheumatology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Jinghua WangDepartment of Rheumatology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Ying SunDepartment of Rheumatology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Zongfei JiDepartment of Rheumatology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Lingying MaDepartment of Rheumatology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Xiaomin DaiDepartment of Rheumatology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Huiyong ChenDepartment of Rheumatology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Lili MaDepartment of Rheumatology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Lindi JiangDepartment of Rheumatology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China. zsh-rheum@hotmail.com.ORCID 0000-0001-7747-7788
Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTakayasu arteritis (TAK) is a chronic granulomatous large vessel vasculitis with multiple immune cells involved. Chemokines play critical roles in recruitment and activation of immune cells. This study aimed to investigate chemokine profile in the peripheral blood and vascular tissue of patients with TAK.

methodsA total of 58 patients with TAK and 53 healthy controls were enrolled. Chemokine array assay was performed in five patients with TAK and three controls. Chemokines with higher levels were preliminarily validated in 20 patients and controls. The validated chemokines were further confirmed in another group of samples with 25 patients and 25 controls. Their expression and distribution were also examined in vascular tissue from 8 patients and 5 controls. Correlations between these chemokines and peripheral immune cells, cytokines, and disease activity parameters were analyzed. Their serum changes were also investigated in these 45 patients after glucocorticoids and immunosuppressive treatment.

resultsPatients and controls were age and sex-matched. Twelve higher chemokines and 4 lower chemokines were found based on the chemokine array. After validation, increase of 5 chemokines were confirmed in patients with TAK, including CCL22, RANTES, CXCL16, CXCL11, and IL-16. Their expressions were also increased in vascular tissue of patients with TAK. In addition, levels of RANTES and IL-16 were positively correlated with peripheral CD3

conclusionsCCL22, RANTES, CXCL16, CXCL11, and IL-16 were identified as the major chemokines involved in the recruitment of immune cells in the vascular tissue of patients with TAK. Additionally, the persistently high levels of CCL22, CXCL11, and IL-16 observed after treatment indicate their role in vascular chronic inflammation or fibrosis and demonstrate the need for developing more efficacious treatment options.

Indexed as

Takayasu ArteritisChemokinesCytokinesHumansInflammationT-LymphocytesChemokinesCytokines

Identifiers

PMID35172901
PMCPMC8848964
OpenAlexW4212883641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.